logo
Select company
Select metric
$ 197.5MWorking Capital
VS
Market
64
Sector
66
Industry
69
History
100
$ 10.8Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information

Ticker

ZVRA

Company Name

ZEVRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZEVRA THERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZVRA - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 226.34M$ 28.83M$ 197.5M
3/31/2025$ 81.57M$ 26.98M$ 54.6M
12/31/2024$ 86.03M$ 34.06M$ 51.96M
9/30/2024$ 99.44M$ 34.48M$ 64.96M
6/30/2024$ 60.89M$ 30.45M$ 30.44M
3/31/2024$ 62.89M$ 29.91M$ 32.98M
12/31/2023$ 86.94M$ 73.72M$ 13.22M
9/30/2023$ 137.01M$ 21.71M$ 115.3M
6/30/2023$ 103.43M$ 18.25M$ 85.17M
3/31/2023$ 104.28M$ 15.62M$ 88.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ -62.65M.
  • Over the past 5 years, ZEVRA THERAPEUTICS INC's average Working Capital has been $ 73.48M.
  • The median Working Capital for ZEVRA THERAPEUTICS INC during this period was $ 80.79M
  • ZEVRA THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 197.5M.
  • The lowest Working Capital recorded by ZEVRA THERAPEUTICS INC in the same timeframe $ -62.65M

ZEVRA THERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
EYPT : EYEPOINT PHARMACEUTICALS INC $ 232.08MTBPH : THERAVANCE BIOPHARMA INC $ 311.66MSAGE : SAGE THERAPEUTICS INC $ 364.44MMGTX : MEIRAGTX HOLDINGS PLC $ -6.35MLXRX : LEXICON PHARMACEUTICALS INC $ 110.25MNKTR : NEKTAR THERAPEUTICS $ 115.17MKURA : KURA ONCOLOGY INC $ 552.9MGOSS : GOSSAMER BIO INC $ 182.3MNRIX : NURIX THERAPEUTICS INC $ 358.25MSNDX : SYNDAX PHARMACEUTICALS INC $ 418.69M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for ZEVRA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 8.14M ] - LiabilitesC [ $ 70.8M ]
(=) Working Capital [ $ -62.65M ]

ZVRA - Working Capital, Last 5 years

$ -62.65M

Minimum

Sep 30, 2020

$ 197.5M

Maximum

Jun 30, 2025

$ 73.48M

Average

$ 80.79M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.42M with a standard deviation of $ 173.65M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.79K
min$ -457.39M
max$ 607.04M
average$ 96.42M
median$ 32.11M
std$ 173.65M